(Total Views: 392)
Posted On: 12/27/2017 10:13:30 AM
Post# of 72447
Beautiful news this morning. I predict Kevetrin will be the first collaboration with a very, very large up front payment. There are tons of $100M+ upfronts on preclinical cancer drugs that have less promise than Kevetrin. The tides will turn shortly and I'm very excited.
How many BPs have a couple billion Trump dollars soon to be laying around? Probably worth securing the rights to the most promising p53 modulator out there, right? Look how lucrative the first-movers in PD-1 immunotherapies are.
Bravo to the IPIX team once again.
Go IPIX!
How many BPs have a couple billion Trump dollars soon to be laying around? Probably worth securing the rights to the most promising p53 modulator out there, right? Look how lucrative the first-movers in PD-1 immunotherapies are.
Bravo to the IPIX team once again.
Go IPIX!
(1)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
